> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meticorten Not Withdrawn Due to Safety/Effectiveness: FDA
- URL: https://www.fdaweb.com/meticorten-not-withdrawn-due-to-safety-effectiveness-fda/
- Published: 2017-12-01T12:00:00.000Z
- Updated: 2026-09-14T23:04:31.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140247

*Federal Register* notice: FDA has determined that Schering’s Meticorten (prednisone) tablets were not withdrawn from sale for reasons of safety or effectiveness. The determination will allow the agency to continue to approve ANDAs that reference the product as long as relevant legal and regulatory requirements are met. The action is in response to a July citizen petition from Strides Pharma. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-12-01/pdf/2017-25900.pdf?ref=fdaweb.com).